000 | 01394 a2200457 4500 | ||
---|---|---|---|
005 | 20250513094449.0 | ||
264 | 0 | _c19961017 | |
008 | 199610s 0 0 eng d | ||
022 | _a0959-4965 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSodhi, M S | |
245 | 0 | 0 |
_aAssociation between clozapine response and allelic variation in the 5-HT2C receptor gene. _h[electronic resource] |
260 |
_bNeuroreport _cDec 1995 |
||
300 |
_a169-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aClozapine _xtherapeutic use |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, Serotonin _xgenetics |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 |
_aSerotonin Antagonists _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aArranz, M J | |
700 | 1 | _aCurtis, D | |
700 | 1 | _aBall, D M | |
700 | 1 | _aSham, P | |
700 | 1 | _aRoberts, G W | |
700 | 1 | _aPrice, J | |
700 | 1 | _aCollier, D A | |
700 | 1 | _aKerwin, R W | |
773 | 0 |
_tNeuroreport _gvol. 7 _gno. 1 _gp. 169-72 |
|
999 |
_c8739500 _d8739500 |